Metformin for the Treatment of Microvascular Dysfunction After Gestational Diabetes

Clinical trial NCT05917587 · RECRUITING

Trial details

NCT number: NCT05917587
Sponsor: Anna Stanhewicz, PhD
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Gestational Diabetes

Start date: 2024-09-11
Primary completion: 2027-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.